Tanguler Tolga sold ALNY

October 2, 2025 · Form 4 insider transaction

Tanguler Tolga sold 117 shares of Alnylam Pharmaceuticals, Inc. at $454.84 per share, a transaction worth $53.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
117
Price
$454.84
Total value
$53.2K
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 2, 2025
Filing dateOctober 3, 2025
Shares owned after27,544
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of a tranche of PSUs granted to the reporting person on March 1, 2024.; The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $454.38 to $455.34. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

View the original Form 4 on SEC EDGAR
Tanguler Tolga sold ALNY: October 2, 2025 | Insider Trading Screener